StonvexLoading…
StonvexStonvexStonvexCore line items from CTNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.29M | $455.81K | $38.32M | $55.15M |
Operating Income | $-4.58M | $-3.74M | $-2.19M | $2.14M |
Net Income | $-3.65M | $-5.19M | $133.87K | $816.98K |
EPS (Diluted) | $-1.12 | $-2.65 | $0.12 | $0.05 |
Total Assets | $11.86M | $15.38M | $10.06M | $14.72M |
Total Liabilities | $2.50M | $2.76M | $3.15M | $12.87M |
Cash & Equivalents | $233.22K | $1.65M | $433.00K | $58.38K |
Free Cash Flow OCF − CapEx | Not available | $-122.78K | Not available | Not available |
Shares Outstanding | 3.42M | 3.22M | 1.12M | 16.67M |